Our Team
Marc Cluzel – Chairman (Non-Executive)

Marc is a biopharmaceutical executive with over 30 years of leadership across R&D, clinical development, and global governance. As former Chief Scientific Officer of Sanofi, he led one of the world’s largest pharmaceutical R&D organizations and oversaw major development programs across multiple therapeutic areas. He later served as Chairman of MorphoSys AG, guiding the company’s strategic direction leading up to its €2.7B acquisition by Novartis, and has held several senior advisory and board roles across Europe and the U.S. Known for strong governance discipline, strategic clarity, and deep experience navigating complex scientific, regulatory, and commercial environments, his international track record provides the board with high level oversight in innovation, risk management, and long term value creation, ensuring strategic alignment as the platform scales.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Emil A. Dublin – CEO

Emil is CEO of Echelon Consolidated, responsible for strategic expansion, disciplined M&A execution, and post acquisition integration in alignment with the Supervisory Board. His background blends investment focus with hands on operational leadership, having led a mid-sized logistics organization through a full turnaround that restored financial stability, strengthened performance, and established sustainable processes. He brings experience across sourcing, evaluating, and structuring mid-market transactions, as well as scaling multi-entity operations. Emil concentrates on building a resilient, high performance platform, ensuring operational continuity, cultural alignment, and long term value creation across all acquired companies.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Robert Baumann – Head of Audit

Robert is a global finance executive with over 30 years of senior leadership across semiconductors, lighting, automation, consumer electronics, and automotive. He has held multiple CFO and EVP roles in multinational groups, leading large finance functions across Europe, Asia, and the Americas. From 2021 to 2025, he served as CFO & EVP of Swisslog AG (€1B+ intralogistics leader), overseeing Finance, IT, Legal, and Procurement while delivering profitable growth and transforming the finance organization. Previously, he was CFO of OSRAM Opto Semiconductors and held senior finance roles at Philips Lighting/Signify, including CFO of the Professional Lighting Business Group, supporting the Philips Lighting IPO and driving margin and cash-flow improvements. He holds a Master’s in Business Administration, a Master’s in Law, and executive qualifications from INSEAD, Wharton, and Philips.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Pieter Oosthoek – CFO

Pieter Oosthoek is a corporate finance executive with over 30 years of experience across multinational corporates, PE-owned businesses, and entrepreneurial ventures. He has held senior finance roles at companies including PepsiCo, Sara Lee, Tech Data/TD Synnex, and HG International B.V., where he served as Acting CFO and delivered substantial EBITDA and cash-flow improvements. Pieter also founded and scaled Sierra Nevada B.V., building a multi-country commercial operation. He brings deep expertise in financial strategy, governance, due diligence, and integration, supporting the platform’s acquisition and growth strategy.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Akina Li – Accountant / Financial Reporting

Akina Li is a finance and accounting specialist with over a decade of experience supporting private equity structures, real estate funds, and multi-entity international groups. She has managed full scope financial reporting, consolidation, regulatory filings, cash-flow forecasting, and audit coordination under Dutch GAAP, and has supported valuation analysis and transaction documentation for cross border M&A projects. Her expertise also includes investor reporting, fund governance compliance, and multi-entity statutory administration. She holds an MBA from Warwick Business School and a Master of Finance and Accounting from Hogeschool Rotterdam, and brings a process driven, precise approach to ensure reliable and timely financial operations for the platform.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Patric Jansen – Head of Legal

Patric Jansen is an experienced corporate legal executive and business leader with more than 25 years of leadership in legal & compliance, global governance and real estate. Proven track record as (supervisory) board member, general counsel, and trusted advisor to executive and supervisory boards. He served as Head Legal & Compliance with Engie Netherlands for 12 years and for 11 years as General Counsel and Board Member for Stork, for which he supported multiple global acquisitions, divestments and restructurings. In 2023 he started his own consultancy with focus on M&A & governance. He holds a Master’s in Law and a Master’s in Business Administration and provides deep legal expertise, sound judgment, negotiation strength, and leadership in complex international environments to the platform.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Stuart Kay – CTO

Stuart Kay is a medtech engineering and manufacturing leader with more than 30 years of experience in device design, automation, process engineering, and operational scale-up. He has helped multiple device companies grow from early-stage operations to globally scaled organizations by building engineering infrastructure, optimizing production systems, and leading multi-site technical teams. His expertise spans product development, regulatory-driven engineering, and advanced manufacturing technologies, providing strong technical direction across the platform’s growth strategy.
BUILDING A STRONGER INDUSTRY
We launched Echelon Consolidated around a straightforward goal: injecting real strength, steady support, and fresh ideas into Europe’s medical device landscape.
Smaller and mid sized firms are often squeezed during market shifts. We take the opposite view. These companies shouldn’t merely survive—they should excel. By bringing together experienced leaders from business, finance, and healthcare, we acquire or invest in firms with solid foundations and help them expand into new markets while preserving their identity and expertise.
Starting in the Netherlands, we are building a dependable European network of medical device companies known for quality, reliability, and long term value creation.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

VALUES
Excellence: We chase top results by nailing every detail in how we blend and run our efforts — no shortcuts.
Reliability: Our medical device solutions stand firm, always putting patient well being and full compliance first.
Integrity: We keep things open, ethical, and trustworthy in every deal and decision we make.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
VISION
Our vision is a European ecosystem where outstanding independent medical device companies thrive. By pairing their innovative spirit with firm support, shared tools, and sustained investment, we aim to drive meaningful improvements in healthcare.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━